DUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported a loss of $718.5 million in its second quarter.
On a per-share basis, the Dublin-based company said it had a loss of $11.74. Losses, adjusted for amortization costs and stock option expense, came to $8.25 per share.
The results fell short of Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for a loss of $6.12 per share.
The drugmaker posted revenue of $1.05 billion in the period, which met Street forecasts.
Jazz expects full-year earnings in the range of $4.80 to $5.60 per share, with revenue in the range of $4.15 billion to $4.3 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
